Table 1.
Patients’ characteristics and clinical data at ERT-naïve baseline
Patient No. | Age, yr | Initial ERT | Current ERT | Infused ERT (current), mg | Time under ERT, mo | GLA Mutation | ACEi/ARB, Yes/No | eGFR, ml/min per 1.73 m2 | LVH, yes/no | Lyso-Gb3, ng/ml | Lyso-Gb3, ng/ml per yr | eGFR, ml/min per 1.73 m2 per yr | IVSd, mm/yr |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 70 | α | α | 17.5 | 63 | p.R301Q | Yes | 65.0 | Yes | 26.7 | −1.9 | −5.4 | +1.7 |
2 | 49 | α | α | 14 | 54 | p.S247P | Yes | 45.0 | Yes | 57.8 | +13.1 | −10.9 | 0.0 |
3 | 48 | α | α | 14 | 46 | c.1090_1103del | Yes | 6.5 | Yes | 55.0 | −4.7 | −0.1a | +0.2 |
4 | 47 | β | β | 70 | 114 | p.L294S | Yes | 37.9 | No | 19.5 | −1.5 | −16.3b | +1.5 |
5 | 44 | β | β | 70 | 192 | p.R220X | No | 99.7 | Yes | 30.4 | −2.1 | −0.5 | −0.1 |
6 | 42 | β | β | 70 | 192 | p.R220X | No | 95.4 | Yes | 70.0 | −4.7 | −2.0 | +0.3 |
7 | 30 | β | β | 70 | 190 | c.762ins282bp | No | 148.8 | No | 21.5 | +2.1 | −1.1 | −0.2 |
8 | 47 | α | β | 70 | 152 | p.C94S | No | 108.5 | No | 45.7 | −5.3 | −3.1 | −0.1 |
9 | 31 | β | β | 70 | 7 | c.723dupT | No | 92.2 | N/A | 112.0 | N/A | −11.8 | N/A |
10 | 46 | α | β | 70 | 145 | p.R227X | Yes | 122.7 | Yes | 110.0 | −18.6 | −0.1 | +0.2 |
11 | 19 | β | β | 70 | 8 | p.R227X | No | 148.9 | Yes | 133.0 | N/A | −3.4 | +0.7 |
12 | 22 | α | α | 14 | 43 | c.702_709del | No | 146.8 | Yes | 155 | −17.4 | −0.9 | +0.1 |
13 | 31 | α | α | 14 | 92 | c.IVS2–2A>G | No | 148.1 | No | 46.9 | −1.7 | −2.6 | −0.4 |
14 | 50 | β | β | 70 | 130 | p.R220X | Yes | 77.8 | Yes | 55.0 | N/A | −0.4 | −0.2 |
15 | 42 | α | α | 14 | 95 | p.M1T | No | 118.4 | Yes | 105.0 | N/A | −3.4 | +0.6 |
16 | 31 | β | β | 70 | 204 | p.R227X | No | 145.0 | No | 41.4 | +0.4 | −1.7 | +0.1 |
17 | 24 | α | α | 14 | 13 | p.Y151X | No | 124.6 | No | 197.0 | −10.1 | −1.3 | +0.1 |
18 | 53 | β | β | 105 | 122 | p.Y173X | No | 47.0 | Yes | 46.9 | −13.1 | −3.9 | +0.2 |
19 | 43 | β | β | 70 | 162 | Deletion E7 | Yes | 117.8 | No | 29.9 | +0.5 | −2.9 | +0.1 |
20 | 39 | α | α | 14 | 47 | p.W349X | Yes | 104.6 | Yes | 164.0 | −28.1 | −3.6 | +0.2 |
21 | 50 | α | α | 17.5 | 191 | p.R220X | Yes | 110.3 | Yes | 107.0 | −12.6 | −3.6 | +0.3 |
22 | 22 | α | β | 55 | 13 | p.C202Y | Yes | 140.0 | Yes | 76.8 | −53.6 | −7.5 | −2.8 |
23 | 47 | β | β | 80 | 24 | p.R227X | Yes | 61.8 | No | 170.0 | −58.4 | −1.7 | 0.0 |
24 | 19 | α | α | 14 | 12 | p.I91T | No | 152.4 | N/A | 12.9 | N/A | N/A | N/A |
25 | 52 | β | β | 70 | 181 | c.1208delAAG | Yes | 120.6 | Yes | 66.2 | −2.9 | −2.2 | +0.2 |
26 | 49 | α | α | 14 | 46 | c.718_719delAA | Yes | 90.5 | Yes | 65.1 | +4.9 | −9.5 | +0.5 |
Total | |||||||||||||
26 | 44 [19–70] | 14 α; 12 β | 11 α; 15 β | 70 [14–105] | 94 [7–204] | 6 missense/20 nonsense | 13 yes; 13 no | 109.4 [6.5–152.4] | 16 yes/8 no | 74.6 [12.9–197.0] | −4.7 [−58.4 to +13.1] | −3.0 [−16.3 to –0.1] | 0.2 [−2.8 to 1.7] |
Values are given as total or mean with range. If no values at ERT-naïve baseline were available, the earliest value is presented. Albuminuria: 0=none, 1=microalbuminuria, 2=macroalbuminuria. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; LVH, left ventricular hypertrophy; N/A, not available.
Dialysis treatment.
Kidney transplantation.